| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |